Form 4 for PCVX Vaxcyte, Inc.

Accepted 2026-03-11 00:00:00 ET · period of report 2026-03-09 · accession 0001813798-26-000005 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-03-11	2026-03-10	PCVX	Wassil Jim	COO	S - Sale	$58.88	-7,395	171.8K	-4%	-$435.4K
	2026-03-11	2026-03-09	PCVX	Wassil Jim	COO	F - Tax	$59.32	-975	174.2K	-0.6%	-$57.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-03-10	S	D	4,968	$59.16	166,818	D	—	—	(F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $58.74 to $59.575. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2026-03-10	S	D	2,427	$58.32	171,786	D	—	—	(F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $57.725 to $58.715. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
3	Common	Common Stock	2026-03-09	F	D	975	$59.32	174,213	D	—	—	(F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person.